Literature DB >> 11052218

Dopamine receptors: from structure to behavior.

S C Sealfon1, C W Olanow.   

Abstract

The responses obtained with drugs that act at dopamine receptors depend on the spectrum of receptors stimulated, the pattern of stimulation and the neuronal signal-transduction pathways that are activated. In the absence of drugs that reliably discriminate between the various cloned receptors, elucidating the role of these receptors has largely relied on molecular genetic approaches that include expression of genes for receptors in cell lines and manipulation of this expression in animal models. Connecting molecular events that occur consequent to receptor stimulation with the resulting physiological effects entails bridging a complex network of interactions. This article reviews the current understanding of the molecular, cellular and systemic consequences of activation of the different dopamine receptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11052218     DOI: 10.1016/s1471-1931(00)00025-2

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  31 in total

Review 1.  Cognitive effects of nicotine: genetic moderators.

Authors:  Aryeh I Herman; Mehmet Sofuoglu
Journal:  Addict Biol       Date:  2010-04-29       Impact factor: 4.280

Review 2.  Functional selectivity in GPCR heterocomplexes.

Authors:  J González-Maeso; S C Sealfon
Journal:  Mini Rev Med Chem       Date:  2012-08       Impact factor: 3.862

3.  Endogenous dopamine (DA) competes with the binding of a radiolabeled D₃ receptor partial agonist in vivo: a positron emission tomography study.

Authors:  Robert H Mach; Zhude Tu; Jinbin Xu; Shihong Li; Lynne A Jones; Michelle Taylor; Robert R Luedtke; Colin P Derdeyn; Joel S Perlmutter; Mark A Mintun
Journal:  Synapse       Date:  2011-03-21       Impact factor: 2.562

4.  Dopaminergic augmentation of delta-9-tetrahydrocannabinol (THC) discrimination: possible involvement of D(2)-induced formation of anandamide.

Authors:  Marcello Solinas; Gianluigi Tanda; Carrie E Wertheim; Steven R Goldberg
Journal:  Psychopharmacology (Berl)       Date:  2010-02-24       Impact factor: 4.530

Review 5.  Monitoring rapid chemical communication in the brain.

Authors:  Donita L Robinson; Andre Hermans; Andrew T Seipel; R Mark Wightman
Journal:  Chem Rev       Date:  2008-06-25       Impact factor: 60.622

6.  Comparison of the binding and functional properties of two structurally different D2 dopamine receptor subtype selective compounds.

Authors:  Robert R Luedtke; Yogesh Mishra; Qi Wang; Suzy A Griffin; Cathy Bell-Horner; Michelle Taylor; Suwanna Vangveravong; Glenn H Dillon; Ren-Qi Huang; David E Reichert; Robert H Mach
Journal:  ACS Chem Neurosci       Date:  2012-10-12       Impact factor: 4.418

7.  Evidence that the BLOC-1 protein dysbindin modulates dopamine D2 receptor internalization and signaling but not D1 internalization.

Authors:  Yukihiko Iizuka; Yoshitatsu Sei; Daniel R Weinberger; Richard E Straub
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

8.  The multiple LIM domain-containing adaptor protein Hic-5 synaptically colocalizes and interacts with the dopamine transporter.

Authors:  Ana M Carneiro; Susan L Ingram; Jean-Martin Beaulieu; Ava Sweeney; Susan G Amara; Sheila M Thomas; Marc G Caron; Gonzalo E Torres
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

Review 9.  Third generation antipsychotic drugs: partial agonism or receptor functional selectivity?

Authors:  Richard B Mailman; Vishakantha Murthy
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

10.  Reciprocal modulation of function between the D1 and D2 dopamine receptors and the Na+,K+-ATPase.

Authors:  Lisa A Hazelwood; R Benjamin Free; David M Cabrera; Mette Skinbjerg; David R Sibley
Journal:  J Biol Chem       Date:  2008-11-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.